Please assess the completion status of the following clinical trial:

Trial Title: Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is male or female at least 18 years of age~* For women of child-bearing potential: woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control~* Patient is scheduled to have a bunionectomy~* Patient must be willing to stay at the study site for at least 48 hours from the initial dose of study medication post-surgery~Exclusion Criteria:~* Patient has a current disease or history of a disease that will impact the study or the patient's well-being~* Patient has used or intends to use any of the medications that are prohibited by the protocol~* Patient has a history of drug or alcohol abuse or dependence, or patient has a positive urine drug screen~* Patient is hypersensitive to any of the medications to be used in the study~* Patient has taken another investigational drug within 30 days prior to Screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Tablet
- Acurox 5/30mg (Type: ACTIVE_COMPARATOR): Oxycodone HCl 5mg/Niacin 30mg tablet
- Acurox 7.5/30 (Type: PLACEBO_COMPARATOR): Oxycodone HCl 7.5mg/Niacin 30mg tablet

Based on this trial design, predict the completion outcome and termination type (if applicable).